Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Equity Ratio (2020 - 2025)

Historic Equity Ratio for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to 0.89.

  • RxSight's Equity Ratio rose 15.89% to 0.89 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.89, marking a year-over-year increase of 15.89%. This contributed to the annual value of 0.88 for FY2024, which is 49.84% up from last year.
  • As of Q3 2025, RxSight's Equity Ratio stood at 0.89, which was up 15.89% from 0.9 recorded in Q2 2025.
  • In the past 5 years, RxSight's Equity Ratio registered a high of 0.9 during Q2 2024, and its lowest value of 3.3 during Q2 2021.
  • In the last 5 years, RxSight's Equity Ratio had a median value of 0.84 in 2023 and averaged 0.57.
  • Examining YoY changes over the last 5 years, RxSight's Equity Ratio showed a top increase of 11997.44% in 2022 and a maximum decrease of 1678.82% in 2022.
  • Over the past 5 years, RxSight's Equity Ratio (Quarter) stood at 0.72 in 2021, then decreased by 16.54% to 0.6 in 2022, then surged by 46.73% to 0.88 in 2023, then increased by 0.5% to 0.88 in 2024, then rose by 1.32% to 0.89 in 2025.
  • Its last three reported values are 0.89 in Q3 2025, 0.9 for Q2 2025, and 0.89 during Q1 2025.